Metzger O, Leone JP, Li T, Tan-Wasielewski Z, et al. Phase I dose-escalation trial of tucatinib in combination with trastuzumab in
patients with HER2-positive breast cancer brain metastases. Ann Oncol 2020 May 24. pii: S0923-7534(20)39835.
PMID: 32461105